The current classification system presents challenges to the diagnosis and treatment of
patients with diabetes mellitus (DM), in part due to its conflicting and confounding definitions …

Slowly progressive type 1 insulin-dependent diabetes mellitus (SPIDDM), sometimes
referred to as latent autoimmune diabetes in adults (LADA), is a heterogeneous disease that …

Abstract Dipeptidyl peptidase-4 (DPP-4) inhibitors constitute a novel class of anti-diabetic
agents confirmed to improve glycemic control and preserve β-cell function in type 2 …

Aims To describe and to characterize clinical features of latent autoimmune diabetes in
adults (LADA) compared to type 1 and type 2 diabetes in the UAE. Methods In this cross …

US9155705B2 - DPP-IV inhibitor combined with a further antidiabetic agent, tablets
comprising such formulations, their use and process for their preparation - Google Patents …

Aims Patients with a type‐2‐diabetes (T2D) phenotype positive for glutamic acid
decarboxylase antibodies (GADA) represent the majority of cases of latent autoimmune …

Background Latent autoimmune diabetes in adults (LADA) is a form of autoimmune diabetes
with heterogeneous features. This study aimed to investigate the persistent status of …

Background The prevalence and incidence of type 1 diabetes mellitus (T1DM) in all age
groups and the prevalence of metabolic syndrome in patients with T1DM in Korea were …

Diabetes mellitus is a complicated disease characterized by a complex interplay of genetic,
epigenetic, and environmental variables. It is one of the world's fastest-growing diseases …

Aims Trabecular bone score (TBS) is a surrogate indicator of bone microarchitecture. The
present study sought to examine the association between type 2 diabetes (T2D) and …